Literature DB >> 20091426

The diminishing role of transurethral resection of the prostate.

Ray M Merrill1, Bradley D Hunter.   

Abstract

BACKGROUND: This study provides an update of patterns in transurethral resection of the prostate (TURP) rates in the United States and the extent of TURP-detected prostate cancer incidence rates.
METHODS: Analyses are based on data from the National Hospital Discharge Survey, the Surveillance, Epidemiology, and End Results Program, and the U.S. Census Bureau for the years 1996 through 2006.
RESULTS: TURP procedure rates were 6, 14, and 18 times greater in men aged 60 to 69, 70 to 79, and >or=80 years compared with men aged 50 to 59, respectively. During 1996-2006, the estimated annual percentage change in TURP rates was -10.5 (95% confidence interval [95% CI] -14.1 to -6.7) for ages 50 to 59, -7.4 (95% CI -9.2 to -5.6) for ages 60 to 69, -6.2 (95% CI -7.6 to -4.8) for ages 70 to 79, and -7.7 (95% CI -9.5 to -5.8) for ages >or=80 years. TURP-detected prostate cancer incidence rates were 2, 7, and 17 times greater in men aged 60 to 69, 70 to 79, and >or=80 years compared with men aged 50 to 59, respectively. The estimated annual percentage change in trend was -17.8 (-20.6, -15.0) for ages 50 to 59, -14.8 (-16.6, -13.0) for ages 60 to 69, -10.8 (-12.0, -9.7) for ages 70 to 79, and -8.2 (-10.0, -6.5) for ages >or=80 years. Trends in prostate cancer incidence rates peaked in 2002 and decreased thereafter. Some of the decreasing trend in rates among older age groups is because of a decrease in TURPs and consequently a decrease in incidental TURP-detected cases.
CONCLUSIONS: TURP procedure rates and incidental TURP-detected prostate cancer incidence rates have declined and will likely continue to decline in the future.

Entities:  

Mesh:

Year:  2010        PMID: 20091426     DOI: 10.1245/s10434-009-0896-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008).

Authors:  Bahaa S Malaeb; Xinhua Yu; A Marshall McBean; Sean P Elliott
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

2.  Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study.

Authors:  Ching-Hsin Chang; Tzu-Ping Lin; Yen-Hwa Chang; William J S Huang; Alex T L Lin; Kuang-Kuo Chen
Journal:  BMC Urol       Date:  2015-05-09       Impact factor: 2.264

3.  Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years.

Authors:  Marlon Perera; Nathan Lawrentschuk; Nayomi Perera; Damien Bolton; David Clouston
Journal:  Prostate Int       Date:  2015-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.